Acute chest pain (ACP) is a common yet challenging symptom frequently encountered in clinical practice. It requires a thorough and systematic approach, given its potential life-threatening implications. This article provides a comprehensive guide on diagnosing and managing ACP in clinical practice.
Diagnosing ACP involves a multi-faceted approach. A detailed history and physical examination are essential to identify potential cardiac and non-cardiac causes. The use of diagnostic tests, such as electrocardiogram (ECG), chest X-ray, and blood tests, can provide valuable information. Advanced imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), may be warranted in certain cases.
The management of ACP is guided by the underlying cause. In cases of suspected myocardial infarction, immediate reperfusion therapy is crucial. For patients with stable angina, medications such as nitrates, beta-blockers, and calcium channel blockers may be used. Non-cardiac causes of ACP, such as gastroesophageal reflux disease and musculoskeletal pain, require specific treatments.
Risk stratification is a vital component in the approach to ACP. Tools such as the GRACE and TIMI risk scores can help identify high-risk patients who may benefit from more aggressive management. These scores incorporate various clinical variables, including age, vital signs, and laboratory results, to predict the risk of adverse outcomes.
ACP is a complex clinical scenario requiring a comprehensive and systematic approach for diagnosis and management. A thorough history, physical examination, appropriate diagnostic testing, and risk stratification are key components in the approach to ACP. By adhering to these principles, clinicians can ensure optimal patient outcomes and minimize the risk of adverse events.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation